Cáceres Méndez Edward Andres

Cáceres Méndez Edward Andres

Auto-generated profile, based on publicly available information

Cáceres Méndez Edward Andres

Departamento de Medicina Interna Pontificia Universidad Javeriana Bogotá Colombia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2026 in Acta Cardiologica
Verified
Journal Article
Closed access
MMMauricio Manrique-Samer
Mauricio Manrique-Samer
NMNicolás Rodríguez Medina
Nicolás Rodríguez Medina
AMAlejandro Mariño
Alejandro Mariño
EMEdward Cáceres Mendez
Edward Cáceres Mendez
ÁGÁngel Alberto García
Ángel Alberto García
Advanced heart failure is a prevalent and burdensome condition, and effective therapies are needed. Ambulatory intermittent levosimendan infusion has been used to reduce cardiovascular events, although response rates vary. This study assessed the LEVO-D score as a predictive tool in patients receiving levosimendan infusions under standardised conditions. We conducted a prospective observational study at the Heart Failure Clinic of a tertiary-level teaching hospital between September 2020 and March 2024. A total of 67 patients received a median of 10 intermittent levosimendan infusions and were followed for a mean duration of 18 months. The performance of the LEVO-D score was assessed using receiver operating characteristic (ROC) curve analysis and descriptive statistics. The patients were elderly, with a mean age of 69.5 years, a high comorbidity burden, and an advanced functional class. All patients received beta-blockers, and most had a high rate of guideline-directed therapy. At 18 months, the mortality rate was 36.2% and the hospitalisation rate was 42%. The LEVO-D score showed good predictive value for hospitalisation (AUC 0.81), moderate predictive value for clinical response (AUC 0.64), and poor predictive value for mortality (AUC 0.58). A cut-off value of ≥1.0 provided the optimal balance between sensitivity and specificity for identifying responders. The LEVO-D score showed consistent discriminatory capacity in our cohort despite a high rate of optimal medical therapy and a low rate of edge-to-edge transcatheter repair, thus supporting its utility and encouraging further validation in diverse clinical settings.

31 August 2026 in Clinical Case Reports
Verified
Journal Article
Open access
DCDiego Armando Pérez Covo
Diego Armando Pérez Covo
MBMaría Camila Bernal Beltrán
María Camila Bernal Beltrán
DODiego Alejandro Ortega
Diego Alejandro Ortega
CBCristian Orlando Porras Bueno
Cristian Orlando Porras Bueno
EGEmilio José Juan Guardela
Emilio José Juan Guardela
ÁPÁngel Alberto García Peña
Ángel Alberto García Peña
Antimalarial cardiotoxicity may mimic lupus myocarditis in systemic lupus erythematosus. We report a 53‐year‐old woman with chronic antimalarial exposure, myocardial injury, biventricular dysfunction, electrical abnormalities, low lupus activity, and no myocardial edema. Chloroquine withdrawal was followed by clinical improvement and left ventricular function recovery, supporting probable antimalarial‐associated cardiomyopathy.

4 March 2025 in Clinical Case Reports
Verified
Journal Article
Open access
POPorras Bueno Cristian Orlando
Porras Bueno Cristian Orlando
CHCruz Buitrago Roberto Hernando
Cruz Buitrago Roberto Hernando
MAMariño Correa Alejandro
Mariño Correa Alejandro
CACáceres Méndez Edward Andres
Cáceres Méndez Edward Andres
EMEugenio Meek
Eugenio Meek
RGRíos Dueñas Edgar Giovanni
Ríos Dueñas Edgar Giovanni
Several diseases have been linked to αB‐crystallin (CRYAB) mutation. However, this mutation is an uncommon cause that has been associated in recent years with the development of dilated cardiomyopathy. We report a case of dilated cardiomyopathy with restrictive physiology due to a CRYAB mutation.

9 July 2026 in Health Science Reports
Verified
Journal Article
Open access
CGCarolina Murgueitio Guzmán
Carolina Murgueitio Guzmán
JEJesús Andrés Beltrán España
Jesús Andrés Beltrán España
ÁPÁngel Alberto García Peña
Ángel Alberto García Peña
ECEdward Cáceres
Edward Cáceres
CDCándida Díaz‐Brochero
Cándida Díaz‐Brochero
LMLuciano Villa Miranda
Luciano Villa Miranda
Background: Alterations in lipid metabolism are key contributors to the development of atherogenesis and the increasing prevalence of atherosclerotic cardiovascular diseases, including coronary artery disease, peripheral arterial disease, and cerebrovascular disease. The triglyceride‐to‐HDL cholesterol (TG/HDL‐c) index is commonly used to assess cardiovascular disease risk; however, its effectiveness in older adults remains unclear. Methods: This study evaluated the association and predictive capacity of the TG/HDL‐c index for cardiometabolic risk factors in older adults from the SABE Colombian study. A cross‐sectional analysis was performed among adults aged ≥ 60 years from the national SABE survey. Univariable and multivariable logistic regression models were constructed to examine associations between the TG/HDL‐c index and diabetes or metabolic syndrome, adjusting for age, sex, BMI, smoking, diet, and physical activity. Discriminatory capacity was assessed using receiver operating characteristic curves, and optimal cut‐off points were determined using the Youden index. Results: A total of 23,694 participants with a median age of 69 years were included; 57.3% were women. The TG/HDL‐c index was independently associated with both diabetes (adjusted OR per 1 SD: 1.25; 95% CI: 1.13–1.37; p < 0.001) and metabolic syndrome (adjusted OR per 1 SD: 2.82; 95% CI: 2.46–3.22; p < 0.001). The index demonstrated a good discriminatory performance for diabetes (AUC = 0.89; 95% CI: 0.86–0.93; cut‐off = 9.17; sensitivity = 0.81; specificity = 0.90) and metabolic syndrome (AUC = 0.86; 95% CI: 0.85–0.88; cut‐off = 8.81; sensitivity = 0.71; specificity = 0.92). In contrast, discriminatory performance was limited for hypertension, prediabetes, cardiovascular disease, and cerebrovascular disease (AUC range 0.52–0.67). Conclusions: The TG/HDL‐c index was independently associated with diabetes and metabolic syndrome and demonstrated good discriminatory performance in this nationally representative sample of older adults. Although these results highlight its potential utility for identifying individuals at higher cardiometabolic risk, further longitudinal studies are needed to validate these findings and determine the prognostic value of TG/HDL‐c for clinical decision‐making in elderly populations.